ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 2456

$641K Total Retail Price of All Prescriptions

Rank: 134 out of 2456

443 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 6,113 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 775 398 1 2
LISINOPRIL 678 353 2 1
OMEPRAZOLE 634 270 3 3
METFORMIN HCL 494 265 4 11
LEVOTHYROXINE SODIUM 389 172 5 4
HYDROCHLOROTHIAZIDE 336 193 6 7
ZOLPIDEM TARTRATE 293 150 7 28
LOVASTATIN 231 145 8 34
CRESTOR 215 152 9 25
CITALOPRAM HBR 205 110 10 14
PROAIR HFA 189 63 11 22
FUROSEMIDE 183 116 12 8
TRAMADOL HCL 177 65 13 24
ALENDRONATE SODIUM 176 153 14 19
ATORVASTATIN CALCIUM 175 111 15 12
ATENOLOL 154 136 16 6
METOPROLOL SUCCINATE 145 85 17 13
WARFARIN SODIUM 143 91 18 9
AMLODIPINE BESYLATE 137 103 19 5
JANUVIA 125 55 20 81
RANITIDINE HCL 123 60 21 31
CYCLOBENZAPRINE HCL 116 40 R 22 77
PANTOPRAZOLE SODIUM 114 73 23 37
METOPROLOL TARTRATE 110 65 24 10
AZITHROMYCIN 107 44 25 60
IBUPROFEN 100 28 26 52
LEVEMIR FLEXPEN 97 44 27 214
NAPROXEN 94 20 28 109
TRICOR 92 23 29 163
PRAVASTATIN SODIUM 90 43 30 15
GABAPENTIN 89 27 31 16
METFORMIN HCL ER 87 34 32 59
GLYBURIDE 83 26 R 33 40
TRAZODONE HCL 83 43 33 17
MECLIZINE HCL 80 50 35 107
FLUOXETINE HCL 80 38 35 45
LOSARTAN POTASSIUM 79 48 37 18
GLIPIZIDE 78 29 38 46
OXYBUTYNIN CHLORIDE ER 73 53 39 94
GEMFIBROZIL 70 22 40 93
QUINAPRIL HCL 69 44 41 110
FENOFIBRATE 68 14 42 68
CEFUROXIME 66 27 43 244
SERTRALINE HCL 66 22 43 21
ALLOPURINOL 65 58 45 27
FLUTICASONE PROPIONATE 64 33 46 30
PAROXETINE HCL 61 40 47 56
BACLOFEN 60 0 48 112
KETOCONAZOLE 59 18 49 221
LORATADINE 55 14 50 376
HYDROXYZINE HCL 55 37 R 50 177
POLYETHYLENE GLYCOL 3350 53 16 52 64
LIPITOR 53 19 52 63
DILTIAZEM 24HR ER 53 45 52 78
LIDODERM 52 49 55 58
DONEPEZIL HCL 51 51 56 23
NEXIUM 50 37 57 80
RISPERIDONE 50 0 57 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.